Deep knowledge on 
 small-molecule drugs and 
 the 100,000 global patents 
 covering them 

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: NATROBA

« Back to Dashboard
Natroba is a drug marketed by Parapro Llc and is included in one NDA. It is available from three suppliers. There are three patents protecting this drug.

This drug has forty-six patent family members in thirty countries.

The generic ingredient in NATROBA is spinosad. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the spinosad profile page.

Summary for Tradename: NATROBA

Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list3

Pharmacology for Tradename: NATROBA

Drug ClassPediculicide

Clinical Trials for: NATROBA

Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Status: Suspended Condition: Scabies

Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Status: Suspended Condition: Scabies

Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation
Status: Completed Condition: Pediculosis

A Pilot Dose Ranging Study of Spinosad Creme Rinse
Status: Completed Condition: Pediculosis Capitis; Head Lice

Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
Status: Completed Condition: Pediculosis

Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
Status: Completed Condition: Pediculus Capitis Infestation

A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis
Status: Completed Condition: Pediculosis Capitis (Head Lice)

NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers
Status: Completed Condition: Head Lice

Phototoxicity Potential of NatrOVA Creme Rinse - 1%
Status: Completed Condition: Head Lice

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parapro Llc
NATROBA
spinosad
SUSPENSION;TOPICAL022408-001Jan 18, 2011RXYes6,342,482<disabled>Y <disabled>
Parapro Llc
NATROBA
spinosad
SUSPENSION;TOPICAL022408-001Jan 18, 2011RXYes<disabled><disabled>
Parapro Llc
NATROBA
spinosad
SUSPENSION;TOPICAL022408-001Jan 18, 2011RXYes7,030,095<disabled>Y <disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: NATROBA

These historical archives are available as an add-on to one-year subscriptions

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parapro Llc
NATROBA
spinosad
SUSPENSION;TOPICAL022408-001Jan 18, 20115,496,931<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: NATROBA

Country Document Number Publication Date
Austria320713Apr 15, 2006
Japan2002519365Jul 02, 2002
European Patent Office0968706Sep 05, 2001
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc